Global Markets

Evonik (EVK GY) Q1 2026 (EUR): Adj. EBITDA 475mln (exp. 464.1mln); FY Outlook 2-2.2bln (exp. 2.06bln)

News detail

This positive earnings development is driven by both higher sales volumes and higher prices, alongside ongoing cost reductions.

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more